Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial (Q46708226)
Jump to navigation
Jump to search
scientific article published on 13 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial |
scientific article published on 13 March 2013 |
Statements
1 reference
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial (English)
1 reference
Essack Mitha
1 reference
H Ralph Schumacher
1 reference
Leon Fouche
1 reference
Shue-Fen Luo
1 reference
Steven P Weinstein
1 reference
George D Yancopoulos
1 reference
Jian Wang
1 reference
Shirletta King-Davis
1 reference
Robert R Evans
1 reference
13 March 2013
1 reference
1 reference
52
1 reference
7
1 reference
1285-1292
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference